Nisa Investment Advisors
LENZ

Nisa Investment Advisors’s LENZ Therapeutics LENZ Stock Holding History

Nisa Investment Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174 Buy
+19
New +$267 ﹤0.01% 2994
2025
Q4 		– Sell
-244
Closed -$11.4K – 3109
2025
Q3 		$11.4K Hold
244
– – ﹤0.01% 2229
2025
Q2 		$7.15K Buy
244
+211
+639% +$5.74K ﹤0.01% 2382
2025
Q1 		$848 Sell
33
-1
-3% -$25 ﹤0.01% 2677
2024
Q4 		$982 Buy
34
+12
+55% +$366 ﹤0.01% 2691
2024
Q3 		$522 Buy
+22
New +$488 ﹤0.01% 2717
2024
Q2 		– Sell
-644
Closed -$14.4K – 2983
2024
Q1 		$14.4K Hold
644
– – ﹤0.01% 1970
2023
Q4 		$11.8K Buy
644
+28
+5% +$462 ﹤0.01% 2005
2023
Q3 		$10.7K Buy
+616
New +$10.7K ﹤0.01% 2161

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Nisa Investment Advisors's LENZ Position: Q1 2026 in Review

Nisa Investment Advisors opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 19 shares worth $174. The stake represents ﹤0.01% of the portfolio and ranks #2994 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in LENZ as recently as Q3 2025.

Nisa Investment Advisors first reported a position in LENZ in Q3 2023 and has held it in 9 quarters since. The position peaked at $14.4K in Q1 2024. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Nisa Investment Advisors held 19 shares of LENZ Therapeutics worth $174 as of Q1 2026.
  • LENZ Therapeutics was a new Nisa Investment Advisors position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2994 holding.
  • Nisa Investment Advisors first reported a position in LENZ Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • Nisa Investment Advisors's LENZ Therapeutics position peaked at $14.4K in Q1 2024.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.